1. Mr. McCullin is 64 years old with Parkinson’s disease. The PMHNP caring for Mr. McCullin wants to start him on a dopamine agonist to help manage and treat his condition. The PHMNP selects this agent because of which action it has on patients like Mr. McCullin?
A.
Dopamine is terminated through multiple mechanisms.
B.
The D2 autoreceptor regulates release of dopamine from the presynaptic neuron.
C.
MAO-B presents in the mitochondria within the presynaptic neuron.
D.
D2 receptors are the primary binding site for dopamine agonists.